Menu

Estonia Offers Free Genetic Testing to Residents

The nationwide experiment will initially include around 100,000 volunteers.

Apr 13, 2018
Diana Kwon

PIXABAY, VIKUCKA

The Estonian government announced last month that it would pay to genotype 100,000 of its citizens as part of its to plan integrate genetic testing into its healthcare system. The country aims to minimize disease risk and promote healthier living through personalized reports generated from the DNA tests.

“Today we have enough knowledge about both the genetic risk of complex diseases and the interindividual variability of the effects of medicines in order to start using this information systematically in everyday healthcare,” Jevgeni Ossinovski, Estonia’s Minister of Health and Labor, says in a statement.

Participants will be required to donate blood and provide consent for their information to be stored at the Estonian databank, Lili Milani, a researcher with the Estonian Genome Center at the University of Tartu, tells the Associated Press. She adds that DNA samples will be screened for more than 600,000 genetic variants associated with heart disease, cancer, and other common ailments—participants can choose to see their results, which will be communicated through family doctors.

Some scientists warn about the potential downsides of receiving such data. “An offer of free genetic profiling may seem tempting but the information is often difficult to interpret, particularly in relation to risk of serious conditions,” Hugh Whittall, director of the UK Nuffield Council on Bioethics, tells New Scientist. “This may well create more questions than answers for those who take part, and in some cases great anxiety.”

Estonia is not the only place offering state-sponsored genetic testing. According to Gizmodo, Dubai plans to sequence the DNA of its entire population and Nevada aims to do the same for 40,000 of its residents.

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.